Mr Mrs Miss Ms Dr Other

Dr
Inge
Muellejans

European Patent Attorney

Edinburgh Office Glasgow Office

Chemistry

Telephone. +44(0) 131 220 7500
Mobile. +44(0) 786 719 8074
Email. imuellejans@hgf.com

Experience

Specialising in the field of chemistry, particularly medical devices, fibres, fabrics, personal care and cosmetics, Inge has over 20 years of experience in the patent profession both in-house and in private practice. She deals with all IP related topics, in particular drafting and prosecuting patent applications, EPO opposition and appeal proceedings, opinions on freedom-to-operate and validity as well as IP strategy and portfolio management.

Inge has extensive experience dealing with freedom-to-operate, infringement and validity opinions which she partly obtained during the 11 years she worked in-house for a leading specialty chemical company in Germany. She has a broad range of expertise handling oppositions and appeals at the EPO as well as drafting and prosecuting patent applications worldwide.

In addition, she has managed global patent portfolios both in private practice and in-house providing strategic advice to patent professionals, marketing and application technology leaders. She also advises on the German law for employee’s inventions.

Inge graduated at RWTH Aachen University in Germany and obtained a PhD in Chemistry at the DWI Aachen while working on projects for the German Federation of Industrial Research Associations (AIF).

After two years of running the search department of a leading personal healthcare company, Inge joined a specialty chemical company where she qualified as a European Patent Attorney. She moved to Scotland in 2012 to work in private practice, before joining the Edinburgh office of HGF in January 2016.

Qualifications

Patent Attorney

Europe


BSC

RWTH Aachen

MSC

RWTH Aachen

PHD

RWTH Aachen

Publications

Managing Intellectual Property firm rankings - IP Stars 2024

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

The FoodTech Series #1 | Medicament, functional food, nutritive product in the same claim 1: when your own examples no longer support the “improvement”

            The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they ruled on an opposition …

Read article

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.